Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 7, 2013
Shank3-Rich2 interaction regulates AMPA receptor recycling and synaptic long-term potentiationFabrice Raynaud, Andrea Janossy, Janine Dahl, et al.
Clinical Genitourinary Cancer|October 22, 2019
Pharmacokinetic/Pharmacodynamic Relationship of Enzalutamide and Its Active Metabolite N-Desmethyl Enzalutamide in Metastatic Castration-Resistant Prostate Cancer PatientsMarie-Liesse Joulia, Edith Carton, Anne Jouinot, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 9, 2018
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patientsRafael Reis, Laurence Labat, Marie Allard, et al.
Bioorganic & Medicinal Chemistry|November 15, 2011
Disulfide and amide-bridged cyclic peptide analogues of the VEGF₈₁₋₉₁ fragment: synthesis, conformational analysis and biological evaluationMaría Isabel García-Aranda, Yasmina Mirassou, Benoit Gautier, et al.
Bioorganic & Medicinal Chemistry|February 26, 2011
Parallel solid-phase synthesis of a small library of linear and hydrocarbon-bridged analogues of VEGF(81-91): potential biological tools for studying the VEGF/VEGFR-1 interactionMaría Isabel García-Aranda, Patricia Marrero, Benoit Gautier, et al.
Nuclear Medicine and Biology|October 4, 2016
[18F]MEL050 as a melanin-targeted PET tracer: Fully automated radiosynthesis and comparison to 18F-FDG for the detection of pigmented melanoma in mice primary subcutaneous tumors and pulmonary metastasesNathalie Rizzo-Padoin, Michael Chaussard, Nicolas Vignal, et al.
Clinical Therapeutics|July 8, 2020
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older PatientsEvelina Cardoso, Monia Guidi, Nihel Khoudour, et al.
Fundamental & Clinical Pharmacology|October 22, 2017
Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French studyLuc Cabel, Benoit Blanchet, Audrey Thomas-Schoemann, et al.
Plos One|August 23, 2012
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary studyPascaline Boudou-Rouquette, Céline Narjoz, Jean Louis Golmard, et al.
Pharmaceutical Research|June 22, 2011
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patientsMichel Tod, Olivier Mir, Natacha Bancelin, et al.
Pageof 14